Medical Estimating drug dose based on pharmacokinetic data

  • Thread starter Thread starter physio
  • Start date Start date
  • Tags Tags
    Data Drugs
AI Thread Summary
Clinicians determine appropriate drug doses using pharmacokinetic (PK) data, which includes parameters like half-life and area under the curve (AUC). These metrics help estimate how a drug behaves in the body, including its absorption, distribution, metabolism, and excretion. In the context of a Phase 1 clinical trial for a chemotherapy drug, PK data is crucial for establishing an effective dose that achieves the desired therapeutic effect without causing toxicity. To translate in vitro effects, such as a compound's efficacy at 0.3 µM, into an in vivo dose, clinicians consider additional factors beyond PK data. These include the drug's bioavailability, the patient's individual characteristics (like weight and metabolic rate), and the therapeutic window. Ultimately, the goal is to ensure that the drug concentration reaches the target level in the bloodstream to achieve the desired effects while minimizing adverse reactions.
physio
Messages
68
Reaction score
1
How do clinicians determine the appropriate drug dose based on pharmacokinetic data? I was reading up on a Phase 1 clinical trial study for a chemo drug and was wondering how do clinicians and doctors come up with the drug dose based on these studies. Do they make use of the pharmacokinetic data such as half-life, AUC etc. to determine the optimum drug dose or do they need additional information (apart from the concentration that would produce the required effects)?

For instance, if a compound exerts it's effect's at 0.3uM in vitro, what parameters are needed to determine the drug dose such that on ingesting that dose the same effects are observed in vivo? Thanks in advance for your replies!
 
Biology news on Phys.org
Deadly cattle screwworm parasite found in US patient. What to know. https://www.usatoday.com/story/news/health/2025/08/25/new-world-screwworm-human-case/85813010007/ Exclusive: U.S. confirms nation's first travel-associated human screwworm case connected to Central American outbreak https://www.reuters.com/business/environment/us-confirms-nations-first-travel-associated-human-screwworm-case-connected-2025-08-25/...
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...
Back
Top